Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(67%)

Phase Distribution

Ph phase_3
1
33%
Ph phase_1
1
33%
Ph not_applicable
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(2)
Other(1)

Detailed Status

Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
terminated267%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)

NCT01294007
terminatedphase_3

Tibial Delayed Healing Pivotal Clinical Trial

NCT01016067
unknownphase_1

A Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery

NCT01224119

Clinical Trials (3)

Showing 3 of 3 trials
NCT01294007Not Applicable

Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)

Terminated
NCT01016067Phase 3

Tibial Delayed Healing Pivotal Clinical Trial

Terminated
NCT01224119Phase 1

A Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3